Cholangitis, Sclerosing
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
188
|
276
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Common Variable Immunodeficiency
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
207
|
85
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Absent speech
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
232
|
72
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Height
|
phenotype |
|
Organism Attribute
|
249
|
517
|
0.100 |
None |
1.000 |
2 |
2
|
2010 |
2013 |
Moderate intellectual disability
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
251
|
94
|
0.100 |
None |
|
0 |
1
|
|
|
Psoriasis vulgaris
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
255
|
80
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Autistic behavior
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
261
|
78
|
0.100 |
None |
|
0 |
1
|
|
|
Uric acid measurement (procedure)
|
phenotype |
|
Laboratory Procedure
|
264
|
1463
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
302
|
92
|
0.010 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Skin Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
363
|
9
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Vitiligo
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
395
|
249
|
0.110 |
None |
1.000 |
2 |
2
|
2010 |
2014 |
Vital capacity
|
phenotype |
|
Clinical Attribute
|
430
|
746
|
0.100 |
None |
1.000 |
2 |
2
|
2017 |
2019 |
Juvenile arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
450
|
128
|
0.110 |
None |
1.000 |
3 |
2
|
2014 |
2018 |
Hyperalgesia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
451
|
4
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Immune System Diseases
|
group |
Immune System Diseases
|
Disease or Syndrome
|
451
|
116
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Adenoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
452
|
213
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Leukemia, T-Cell
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
457
|
10
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Squamous cell carcinoma of skin
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
458
|
92
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Feeding difficulties
|
phenotype |
|
Finding
|
473
|
62
|
0.400 |
None |
1.000 |
3 |
1
|
2015 |
2019 |
Migraine Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
512
|
264
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Celiac Disease
|
disease |
Digestive System Diseases; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
527
|
263
|
0.400 |
None |
1.000 |
4 |
3
|
2010 |
2016 |
Neurodevelopmental Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
535
|
14
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2020 |
Adenocarcinoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
543
|
432
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Delayed speech and language development
|
phenotype |
Behavior and Behavior Mechanisms
|
Finding
|
560
|
192
|
0.100 |
None |
|
0 |
1
|
|
|
Waist-Hip Ratio
|
phenotype |
|
Organism Attribute
|
565
|
1138
|
0.100 |
None |
1.000 |
3 |
3
|
2018 |
2019 |